OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1308-1308
Open Access | Times Cited: 12
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1308-1308
Open Access | Times Cited: 12
Showing 12 citing articles:
From MASLD to HCC: What's in the middle?
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35338-e35338
Open Access | Times Cited: 5
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35338-e35338
Open Access | Times Cited: 5
Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
Dong‐Wook Han, KangHe Xu, Zhe‐Long Jin, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3595-3613
Open Access | Times Cited: 11
Dong‐Wook Han, KangHe Xu, Zhe‐Long Jin, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3595-3613
Open Access | Times Cited: 11
Diagnostic value of triglyceride–glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study
Rong Yu, Weijiang Xie, Hewei Peng, et al.
BMJ Open (2023) Vol. 13, Iss. 9, pp. e075413-e075413
Open Access | Times Cited: 10
Rong Yu, Weijiang Xie, Hewei Peng, et al.
BMJ Open (2023) Vol. 13, Iss. 9, pp. e075413-e075413
Open Access | Times Cited: 10
Therapeutic potential of stem cell‐derived somatic cells to treat metabolic dysfunction‐associated steatotic liver disease and diabetes
Eduardo Hideo Gilglioni, Mayank Bansal, Wadsen St‐Pierre‐Wijckmans, et al.
Obesity Reviews (2025)
Closed Access
Eduardo Hideo Gilglioni, Mayank Bansal, Wadsen St‐Pierre‐Wijckmans, et al.
Obesity Reviews (2025)
Closed Access
Metabolic mechanisms of immunotherapy resistance
Luís Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio‐Cabello, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Luís Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio‐Cabello, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Qiulin Wu, Yan Yang, Shixun Lin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Qiulin Wu, Yan Yang, Shixun Lin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi
Cancers (2023) Vol. 15, Iss. 18, pp. 4566-4566
Open Access | Times Cited: 9
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi
Cancers (2023) Vol. 15, Iss. 18, pp. 4566-4566
Open Access | Times Cited: 9
Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
Samuel J. Martínez‐Domínguez, Sandra G. García, Viviana Laredo, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3367-3367
Open Access | Times Cited: 8
Samuel J. Martínez‐Domínguez, Sandra G. García, Viviana Laredo, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3367-3367
Open Access | Times Cited: 8
The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma
Nan Hu, Haiyang Li, Changcheng Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5584-5584
Open Access | Times Cited: 3
Nan Hu, Haiyang Li, Changcheng Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5584-5584
Open Access | Times Cited: 3
A microvascularized in vitro liver model for disease modeling and drug discovery
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
Biofabrication (2024) Vol. 17, Iss. 1, pp. 015007-015007
Open Access | Times Cited: 1
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
Biofabrication (2024) Vol. 17, Iss. 1, pp. 015007-015007
Open Access | Times Cited: 1
The Associations between the Tyg Index and the Risk of Common Chronic Non-Communicable Diseases -A Systematic Review and Meta-Analysis
Hongyu Li, Guoheng Jiang, Min Mao, et al.
(2024)
Closed Access
Hongyu Li, Guoheng Jiang, Min Mao, et al.
(2024)
Closed Access
A microvascularized in vitro liver model for disease modeling and drug discovery
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
